First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease

Table 2 Comparison of the complete symptom resolution rates and night-time breakthrough heartburn between dexlansoprazole and esomeprazole over one week [n = 81, n (%)]

Variables	Dexlansoprazole	Esomeprazole	P value
CSR Day 1	21 (25.9)	23 (28.4)	0.724
CSR Day 3	27 (33.3)	26 (32.1)	0.867
CSR Day 7	42 (51.9)	39 (48.1)	0.637
Night reflux	45 (76.3)	40 (74.1)	0.787
Night heart burn	20 (33.9)	18 (33.3)	0.949
Night acid reflux	20 (33.9)	19 (35.2)	0.886
Frequency of night symptoms	2.7 ± 2.0	2.7 ± 2.4	0.343

CSR: Complete symptom resolution.